Perceived Institutional Barriers Among Clinical and Research Professionals: Minority Participation in Oncology Clinical Trials.
Soumya J NiranjanJennifer A WenzelMichelle Y MartinMona N FouadSelwyn M VickersBadrinath R KonetyRaegan W DurantPublished in: JCO oncology practice (2021)
Our research highlights the need to address institutional barriers to improve the success of minority recruitment. To increase participation among minority populations, medical centers must address mutable institutional barriers such as setting specific minority recruitment goals for cancer clinical trials, ensuring that cancer clinical trials are accessible, especially to minority patients, and supporting sustained community outreach programs to increase clinical research awareness.
Keyphrases
- clinical trial
- papillary thyroid
- physical activity
- healthcare
- end stage renal disease
- squamous cell
- mental health
- chronic kidney disease
- ejection fraction
- newly diagnosed
- depressive symptoms
- prognostic factors
- palliative care
- social support
- squamous cell carcinoma
- lymph node metastasis
- phase iii
- double blind
- young adults
- childhood cancer